Cannabis - Sale and Distribution - Tetrahydrocannabinol Offenses
HB12 updates Maryland’s cannabis and criminal laws to regulate products containing tetrahydrocannabinol (THC), with a particular focus on intoxicating hemp-derived products such as delta-8 and delta-10 THC. The bill prohibits the sale or distribution of certain THC products intended for human consumption or inhalation unless they meet specified potency limits and, if applicable, licensing, manufacturing, testing, packaging, and labeling requirements. It also bars the sale of cannabinoid products that are not derived from naturally occurring biologically active chemical constituents, and creates a limited exception for certain hemp-derived tinctures that meet strict CBD-to-THC ratios and testing requirements.
The bill also adds enforcement tools. It authorizes the Alcohol, Tobacco, and Cannabis Commission’s Field Enforcement Division to issue citations for violations of the criminal law provision, and it allows the Executive Director to seize, destroy, or confiscate unlawful products offered in unlicensed locations. For non-licensees, violations of the new THC product rules can be charged by citation and prosecuted as misdemeanors with fines up to $5,000; licensed cannabis businesses face disciplinary action instead. The bill also amends existing law to treat the display or offering of THC products for sale as prima facie evidence of unlawful sale in certain prosecutions, and it reinforces age restrictions by prohibiting sales of delta-8 and delta-10 THC products to anyone under 21 and requiring age-verification on websites.
The overall sentiment reflected in the voting history appears supportive of the bill. It passed the House 95-36 and the Senate 47-0, indicating broad bipartisan agreement in the legislature, with especially strong support in the Senate. No committee transcript discussion was provided, so the available record does not show detailed floor or committee arguments, but the final votes suggest the measure was viewed as a consumer-protection and enforcement bill rather than a controversial expansion of cannabis regulation.
The main points of contention likely centered on how broadly the state should regulate hemp-derived intoxicating products and how aggressively to enforce those rules against retailers and distributors. The bill distinguishes between licensed cannabis businesses and unlicensed sellers, imposes criminal penalties on non-licensees, and gives regulators authority to seize products, which could raise concerns among hemp retailers, convenience stores, and online sellers. Supporters likely emphasized youth access prevention, product safety, and closing loopholes in the THC marketplace, while opponents may have been concerned about regulatory burden, product confiscation, and the impact on lawful hemp-derived tinctures and related businesses.
HB12 amends the Alcoholic Beverages and Cannabis Article and the Criminal Law Article to create new restrictions on THC-containing products, especially intoxicating hemp-derived products, and to expand enforcement authority for the Alcohol, Tobacco, and Cannabis Commission. It establishes potency, packaging, labeling, and licensing requirements for certain THC products, creates a narrow exception for compliant hemp-derived tinctures, and adds misdemeanor penalties, citation authority, and seizure powers for unlawful sales. It also strengthens age-verification and under-21 sales prohibitions for delta-8 and delta-10 THC products.
The bill appears to have been received favorably overall, based on its strong passage in both chambers. The House approved it 95-36 and the Senate passed it unanimously 47-0, suggesting broad legislative support and limited formal opposition at final vote. The absence of committee transcript material limits insight into detailed debate, but the vote margins indicate the bill was generally seen as a reasonable regulatory and enforcement measure.
Likely areas of disagreement include the scope of the THC restrictions, the treatment of hemp-derived intoxicating products, and the enforcement powers granted to regulators. Retailers and hemp-product sellers may object to the low potency thresholds, the ban on certain cannabinoid products, and the ability of the Commission to seize or destroy products. Supporters, by contrast, would likely focus on preventing youth access, reducing misleading advertising, and ensuring that intoxicating products are sold only through licensed and regulated channels.